论文部分内容阅读
合成了具有良好排钚效能的螯合药物3·4·3-LICAMC,改进了实验条件,由实验结果预测羧化儿茶酚类螯合剂具有潜在口服有效性。
The chelating agent 3 · 4 · 3-LICAMC with good plutonium efficiency was synthesized and the experimental conditions were improved. The experimental results predicted the potential oral availability of carboxylated catechol chelators.